News and Press

Sign up now for the latest IR news, and updates on ongoing developments at Avicanna Inc:

Avicanna (TSX: AVCN) Announces Receipt of the First Colombian USDA Organic Certification for its Hemp Cultivation and Registration of 15 Additional Genetics
Avicanna Commences Trading on the OTCQX Market in the United States
Avicanna (TSX: AVCN) Announces First Commercial Sale of the Pura Earth Derma-Cosmetics line of CBD Products
Avicanna (TSX: AVCN) to Open its Next Phase Extraction Facility in Colombia’s Free Trade Zone
Avicanna (TSX: AVCN) Aras Azadian, CEO & Co-Founder to speak at the 12th Annual International Natural & Organic Cosmetics Conference About Organic CBD Skin Care and Pura Earth™ in Berlin, Germany
Avicanna (TSX: AVCN) Enters an Exclusive Research Agreement with the University of Guelph for Proprietary Cannabinoid-based Products and Formulations to Treat Psychiatric Disorders
Avicanna Strengthens Position as a Canadian Leader in Cannabinoid R&D Through University of Toronto Collaboration & University of Guelph Agreements
Avicanna (TSX: AVCN) Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes
Avicanna Secures Canadian Cannabinoid Research Licence at its Headquarters in Toronto’s Discovery District
Avicanna Reports Second Quarter 2019 Financial Results
Avicanna announces joint venture with Sigma Analytical Services Inc., to establish the first GMP/GLP level cannabis quality assurance laboratory in South America
View from the C-Suite: Aras Azadian, Chief Executive Officer, Avicanna Inc., tells his company’s story.